817 related articles for article (PubMed ID: 29155164)
21. Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1.
Dávola ME; Mazaira GI; Galigniana MD; Alché LE; Ramírez JA; Barquero AA
Antiviral Res; 2015 Oct; 122():55-63. PubMed ID: 26259812
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
Caliaro O; Barbani MT; Klenja S; Morfin F; Frobert E; Gorgievski M; Steinlin-Schopfer J; Suter-Riniker F
J Clin Virol; 2020 Apr; 125():104303. PubMed ID: 32163870
[TBL] [Abstract][Full Text] [Related]
23. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
[TBL] [Abstract][Full Text] [Related]
24. Peptide inhibitors against herpes simplex virus infections.
Galdiero S; Falanga A; Tarallo R; Russo L; Galdiero E; Cantisani M; Morelli G; Galdiero M
J Pept Sci; 2013 Mar; 19(3):148-58. PubMed ID: 23389903
[TBL] [Abstract][Full Text] [Related]
25. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.
Levin MJ; Bacon TH; Leary JJ
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S248-57. PubMed ID: 15494896
[TBL] [Abstract][Full Text] [Related]
26. Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence.
Omura N; Fujii H; Yoshikawa T; Yamada S; Harada S; Inagaki T; Shibamura M; Takeyama H; Saijo M
Virol J; 2017 Mar; 14(1):59. PubMed ID: 28320407
[TBL] [Abstract][Full Text] [Related]
27. Aciclovir resistance among Indian strains of Herpes simplex virus as determined using a dye uptake assay.
Abraham AM; Kavitha S; Joseph P; George R; Pillay D; Malathi J; Jesudason MV; Sridharan G
Indian J Med Microbiol; 2007 Jul; 25(3):260-2. PubMed ID: 17901647
[TBL] [Abstract][Full Text] [Related]
28. Bacterial Pigment Prodigiosin Demonstrates a Unique Antiherpesvirus Activity That Is Mediated through Inhibition of Prosurvival Signal Transducers.
Suryawanshi RK; Koujah L; Patil CD; Ames JM; Agelidis A; Yadavalli T; Patil SV; Shukla D
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295926
[TBL] [Abstract][Full Text] [Related]
29. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses.
Toscani A; Denaro R; Pacheco SFC; Biolatti M; Anselmi S; Dell'Oste V; Castagnolo D
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443515
[TBL] [Abstract][Full Text] [Related]
31. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
[TBL] [Abstract][Full Text] [Related]
32. Oral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1.
Duan J; Liuzzi M; Paris W; Liard F; Browne A; Dansereau N; Simoneau B; Faucher AM; Cordingley MG
Antimicrob Agents Chemother; 2003 Jun; 47(6):1798-804. PubMed ID: 12760851
[TBL] [Abstract][Full Text] [Related]
33. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
[TBL] [Abstract][Full Text] [Related]
34. 2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.
Strand M; Islam K; Edlund K; Oberg CT; Allard A; Bergström T; Mei YF; Elofsson M; Wadell G
Antimicrob Agents Chemother; 2012 Nov; 56(11):5735-43. PubMed ID: 22908173
[TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.
Sanchez MD; Ochoa AC; Foster TP
Antiviral Res; 2016 Aug; 132():13-25. PubMed ID: 27192555
[TBL] [Abstract][Full Text] [Related]
36. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
37. Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice.
Bhutta MS; Sausen DG; Reed KM; Gallo ES; Hair PS; Lassiter BP; Krishna NK; Cunnion KM; Borenstein R
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452288
[TBL] [Abstract][Full Text] [Related]
38. [Herpes simplex virus resistance to antivirals].
Burrel S; Topalis D; Boutolleau D
Virologie (Montrouge); 2020 Oct; 24(5):325-342. PubMed ID: 33111706
[TBL] [Abstract][Full Text] [Related]
39. New strategies against drug resistance to herpes simplex virus.
Jiang YC; Feng H; Lin YC; Guo XR
Int J Oral Sci; 2016 Mar; 8(1):1-6. PubMed ID: 27025259
[TBL] [Abstract][Full Text] [Related]
40. Mangiferin: A promising natural xanthone from Mangifera indica for the control of acyclovir - resistant herpes simplex virus 1 infection.
Rechenchoski DZ; Agostinho KF; Faccin-Galhardi LC; Lonni AASG; da Silva JVH; de Andrade FG; Cunha AP; Ricardo NMPS; Nozawa C; Linhares REC
Bioorg Med Chem; 2020 Feb; 28(4):115304. PubMed ID: 31956052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
